Table of Content

1 INTRODUCTION (Page No. - 17)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY CONSIDERED 
    1.6 LIMITATIONS 
    1.7 STAKEHOLDERS 
2 RESEARCH METHODOLOGY (Page No. - 20)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES: ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
          FIGURE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SIZE (USD MILLION)
          FIGURE 5 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022−2027)
          FIGURE 6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.3 MARKET DATA ESTIMATION AND TRIANGULATION 
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.4 INDUSTRY INSIGHTS 
    2.5 RESEARCH ASSUMPTIONS 
3 EXECUTIVE SUMMARY (Page No. - 27)
    FIGURE 8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY COUNTRY, 2021
4 PREMIUM INSIGHTS (Page No. - 31)
    4.1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW 
          FIGURE 13 REDUCED COST OF NEXT-GENERATION SEQUENCING TO DRIVE MARKET GROWTH
    4.2 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT (2021) 
          FIGURE 14 CONSUMABLES SEGMENT DOMINATED MARKET IN JAPAN
    4.3 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION (2021) 
          FIGURE 15 TRANSLATIONAL RESEARCH SEGMENT DOMINATED MARKET IN CHINA
5 MARKET OVERVIEW (Page No. - 33)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 16 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Reduced cost of next-generation sequencing
                    5.2.1.2 Increasing adoption of spatial genomics and transcriptomics in drug discovery and development
           5.2.2 RESTRAINTS
                    5.2.2.1 High capital investments
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing demand for single-cell analysis
           5.2.4 CHALLENGES
                    5.2.4.1 Analytical limitations associated with spatial techniques
    5.3 TECHNOLOGY ANALYSIS 
          TABLE 2 FIVE BENCHMARK COMPUTATIONAL METHODS: COMPARATIVE ANALYSIS
    5.4 VALUE CHAIN ANALYSIS 
          TABLE 3 INDICATIVE LIST OF DISTRIBUTORS FOR KEY MARKET PLAYERS IN ASIA PACIFIC
          FIGURE 17 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 18 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
    5.6 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.6.1 THREAT OF NEW ENTRANTS
           5.6.2 THREAT OF SUBSTITUTES
           5.6.3 BARGAINING POWER OF BUYERS
           5.6.4 BARGAINING POWER OF SUPPLIERS
           5.6.5 INTENSITY OF COMPETITIVE RIVALRY
    5.7 REGULATORY ANALYSIS 
           5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.8 PRICING ANALYSIS 
          TABLE 6 PRODUCT PRICING: KEY MARKET PLAYERS
           5.8.1 AVERAGE SELLING PRICE TREND
    5.9 KEY CONFERENCES AND EVENTS (2020–2023) 
          TABLE 7 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2020–2023)
    5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
           5.10.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET IN ASIA PACIFIC REGION
                     FIGURE 20 KEY BUYING CRITERIA FOR END USERS
6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT (Page No. - 44)
    6.1 INTRODUCTION 
          TABLE 8 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 CONSUMABLES 
           6.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE GROWTH
                    TABLE 9 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 INSTRUMENTS 
           6.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET
                    TABLE 10 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 SOFTWARE 
           6.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE
                    TABLE 11 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE (Page No. - 48)
    7.1 INTRODUCTION 
          TABLE 12 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
    7.2 SPATIAL TRANSCRIPTOMICS 
          TABLE 13 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.1 IMMUNOHISTOCHEMISTRY
                    7.2.1.1 Emergence of mIHC/IF to propel growth
                                TABLE 15 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.2 IN SITU HYBRIDIZATION
                    7.2.2.1 High adoption of MERFISH to drive growth
                                TABLE 16 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.3 SPATIAL TRANSCRIPTOMIC SEQUENCING
                    TABLE 17 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.3.1 Microdissection-based sequencing
                               7.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth
                    7.2.3.2 In situ sequencing
                               7.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth
                    7.2.3.3 Other sequencing technologies
           7.2.4 MICROSCOPY-BASED RNA IMAGING
                    7.2.4.1 Increasing use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth
                                TABLE 18 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.5 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
                    TABLE 19 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 SPATIAL GENOMICS ANALYSIS 
          TABLE 20 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 21 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.1 FLUORESCENCE IN SITU HYBRIDIZATION
                    7.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support growth
                                TABLE 22 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.2 SPATIAL GENOMIC SEQUENCING
                    7.3.2.1 Rising adoption of massively parallel sequencing to drive growth
                                TABLE 23 ASIA PACIFIC: SPATIAL GENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES
                    TABLE 24 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION (Page No. - 58)
    8.1 INTRODUCTION 
          TABLE 25 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 TRANSLATIONAL RESEARCH 
           8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE GROWTH
                    TABLE 26 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 DRUG DISCOVERY AND DEVELOPMENT 
           8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE GROWTH
                    TABLE 27 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER (Page No. - 62)
    9.1 INTRODUCTION 
          TABLE 28 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 ACADEMIC AND RESEARCH INSTITUTES 
           9.2.1 INCREASING DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH
                    TABLE 29 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 CONTRACT RESEARCH ORGANIZATIONS 
           9.3.1 INCREASING NUMBER OF CROS FORMING STRATEGIC PARTNERSHIPS WITH GENOMICS PROVIDERS TO DRIVE GROWTH
                    TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 
           9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS SYSTEMS
                    TABLE 31 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY (Page No. - 66)
     10.1 INTRODUCTION 
             TABLE 32 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
     10.2 CHINA 
             10.2.1 INCREASING R&D SPENDING BY GOVERNMENT AND BIOPHARMA COMPANIES TO SUPPORT MARKET GROWTH
                        TABLE 33 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 34 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 35 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 36 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 37 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 38 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.3 JAPAN 
             10.3.1 RISING FUNDING IN JAPAN TO BOOST RESEARCH APPLICATIONS
                        TABLE 39 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 40 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 41 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 42 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 43 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 44 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.4 INDIA 
             10.4.1 COLLABORATIONS BETWEEN HOSPITALS AND DIAGNOSTIC CENTERS FOR LABORATORY SERVICES TO BOOST GROWTH
                        TABLE 45 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 46 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 47 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 48 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 49 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 50 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.5 REST OF ASIA PACIFIC 
             TABLE 51 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 52 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 53 REST OF ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 54 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 55 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 56 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 78)
     11.1 INTRODUCTION 
     11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 21 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS) 
     11.4 MARKET SHARE ANALYSIS (2021) 
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                       FIGURE 24 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (2021)
     11.6 COMPETITIVE SCENARIO AND TRENDS 
             11.6.1 DEALS
                       TABLE 57 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DEALS
                        11.6.1.1 Product launches
                                     TABLE 58 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES
                        11.6.1.2 Other developments
                                     TABLE 59 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS
12 COMPANY PROFILES (Page No. - 86)
     12.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 NANOSTRING
                        TABLE 60 NANOSTRING: BUSINESS OVERVIEW
                        FIGURE 25 NANOSTRING: COMPANY SNAPSHOT (2021)
             12.1.2 10X GENOMICS
                        TABLE 61 10X GENOMICS: BUSINESS OVERVIEW
                        FIGURE 26 10X GENOMICS: COMPANY SNAPSHOT (2021)
             12.1.3 ILLUMINA
                        TABLE 62 ILLUMINA: BUSINESS OVERVIEW
                        FIGURE 27 ILLUMINA: COMPANY SNAPSHOT (2021)
             12.1.4 BIO-RAD LABORATORIES, INC.
                        TABLE 63 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
             12.1.5 BIO-TECHNE
                        TABLE 64 BIO-TECHNE: BUSINESS OVERVIEW
                        FIGURE 29 BIO-TECHNE: COMPANY SNAPSHOT (2021)
             12.1.6 STANDARD BIOTOOLS
                        TABLE 65 STANDARD BIOTOOLS: BUSINESS OVERVIEW
                        FIGURE 30 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)
             12.1.7 AKOYA BIOSCIENCES
                        TABLE 66 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
                        FIGURE 31 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)
             12.1.8 S2 GENOMICS
                        TABLE 67 S2 GENOMICS: BUSINESS OVERVIEW
             12.1.9 CANTATA BIO
                        TABLE 68 CANTATA BIO: BUSINESS OVERVIEW
             12.1.10 VIZGEN CORP.
                        TABLE 69 VIZGEN: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS 
             12.2.1 BGI GROUP
             12.2.2 MILTENYI BIOTEC
             12.2.3 BRUKER
             12.2.4 PERKINELMER INC.
             12.2.5 NOVOGENE CO., LTD.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 128)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS